Amelioration of visual deficits and visual system pathology after mild TBI with the cannabinoid type-2 receptor inverse agonist SMM-189.
Exp Eye Res. 2019 May;182:109-124. doi: 10.1016/j.exer.2019.03.013. Epub 2019 Mar 26.
Exp Eye Res. 2019.
PMID: 30922891
Free PMC article.